ReviewJournal of molecular medicine (Berlin, Germany)2004
Pathology and molecular genetics of oligodendroglial tumors.
Review in Journal of molecular medicine (Berlin, Germany), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 52 citations in OpenAlex.
- Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective.The protein journal · 2021Review
- High frequency of the X-chromosome inactivation in young female patients with high-grade glioma.Diagnostic pathology · 2013Article
- Article
- Detection of 1p19q deletion by real-time comparative quantitative PCR.Biomarker insights · 2012Article
- Biology, genetics and imaging of glial cell tumours.The British journal of radiology · 2011Review
- French brain tumor database: 5-year histological results on 25 756 cases.Brain pathology (Zurich, Switzerland) · 2011Article
- Gene expression in oligodendroglial tumors.Cellular oncology (Dordrecht, Netherlands) · 2011Article
- Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.Neuro-oncology · 2010Article
- Recent insights into PDGF-induced gliomagenesis.Brain pathology (Zurich, Switzerland) · 2010Review
- Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.BMC neurology · 2009Article
- Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes.Cancer research · 2009Article
- Histology far away from Flatland: 3D roller-coasting into grade-dependent angiogenetic patterns in oligodendrogliomas.Journal of cellular and molecular medicine · 2008Article
- DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.Brain pathology (Zurich, Switzerland) · 2007Article
- French brain tumor data bank: methodology and first results on 10,000 cases.Journal of neuro-oncology · 2007Article
- Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.British journal of cancer · 2006Article
- High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.Cancer research · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oligodendroglial gliomas are second only to astrocytic gliomas in frequency. The lack of stringent diagnostic criteria cause high interobserver variation in regard to classification and grading of these tumors. Previous studies have described oligodendrogliomas with features that overlap with those of neurocytic tumors, thus further complicating diagnostic decisions. The increasing need for standardized diagnostic criteria in this subset of gliomas is emphasized by the benefit of adjuvant therapies in patients with anaplastic oligodendrogliomas. Characteristic chromosomal aberrations have been successfully determined for oligodendroglial tumors in recent years. In contrast to astrocytomas, however, no genes in the affected regions have been clearly linked to their pathogenesis. However, the molecular findings promise to be helpful for diagnostic and therapeutic decisions. This review compiles clinical, pathological, and molecular genetic findings on WHO grades II and III oligodendrogliomas and oligoastrocytomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.